Sandra T Davidge Selected Research

Enzymes

12/2018	Effect of high dose folic acid supplementation in pregnancy on pre-eclampsia (FACT): double blind, phase III, randomised controlled, international, multicentre trial.
1/2017	Loss of smooth muscle cell disintegrin and metalloproteinase 17 transiently suppresses angiotensin II-induced hypertension and end-organ damage.
5/2012	Lectin-like oxidized low-density lipoprotein 1 receptor in a reduced uteroplacental perfusion pressure rat model of preeclampsia.
10/2009	Evidence for increased methylglyoxal in the vasculature of women with preeclampsia: role in upregulation of LOX-1 and arginase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sandra T Davidge Research Topics

Disease

26	Hypoxia (Hypoxemia) 09/2023 - 02/2005
21	Pre-Eclampsia (Preeclampsia) 10/2023 - 02/2002
17	Inflammation (Inflammations) 02/2024 - 06/2008
15	Hypertension (High Blood Pressure) 06/2022 - 03/2008
10	Cardiovascular Diseases (Cardiovascular Disease) 06/2022 - 07/2004
8	Atherosclerosis 01/2013 - 02/2002
6	Vascular Diseases (Vascular Disease) 07/2014 - 04/2004
5	Body Weight (Weight, Body) 02/2024 - 02/2003
5	Fetal Weight 11/2023 - 01/2013
5	Fetal Growth Retardation (Intrauterine Growth Retardation) 12/2015 - 08/2010
4	Insulin Resistance 10/2018 - 02/2011
4	Ischemia 01/2017 - 03/2006
3	Hypertrophy 03/2021 - 01/2017
3	Hyperglycemia 01/2015 - 11/2009
3	Vascular Remodeling 07/2014 - 05/2003
2	Weight Gain 01/2020 - 01/2015
2	Fetal Hypoxia 01/2020 - 01/2019
2	Gestational Diabetes (Gestational Diabetes Mellitus) 02/2017 - 01/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 09/2011
2	Hypotension (Low Blood Pressure) 04/2013 - 07/2009
2	Fibrosis (Cirrhosis) 01/2013 - 03/2010
2	Glucose Intolerance 09/2011 - 02/2011
1	Hypercholesterolemia 01/2024
1	Anemia 11/2023
1	Obesity 10/2022

Drug/Important Bio-Agent (IBA)

10	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2024 - 11/2005
10	Angiotensin IIIBA 06/2022 - 04/2004
10	Estrogens (Estrogen)FDA Link 01/2016 - 02/2003
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2018 - 01/2003
7	AntioxidantsIBA 09/2023 - 11/2009
7	Superoxides (Superoxide)IBA 01/2019 - 01/2010
7	ResveratrolIBA 01/2017 - 09/2011
6	Oxygen (Dioxygen)IBA 12/2022 - 01/2004
6	Endothelin-1 (Endothelin 1)IBA 10/2013 - 02/2005
6	Matrix Metalloproteinases (MMPs)IBA 03/2010 - 02/2003
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2003
5	Peptides (Polypeptides)IBA 06/2022 - 07/2014
5	oxidized low density lipoproteinIBA 01/2020 - 02/2009
5	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2018 - 02/2005
5	CytokinesIBA 01/2018 - 04/2004
5	Peroxynitrous Acid (Peroxynitrite)IBA 01/2012 - 02/2002
4	Methacholine Chloride (Methacholine)FDA Link 01/2024 - 09/2004
4	mitoquinoneIBA 01/2020 - 01/2017
4	LipidsIBA 01/2020 - 10/2009
4	EnzymesIBA 12/2018 - 10/2009
4	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2014 - 01/2003
3	Class E Scavenger Receptors (Lectin Like Oxidized Low Density Lipoprotein Receptor 1)IBA 10/2023 - 02/2009
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2015
3	Insulin (Novolin)FDA Link 10/2018 - 02/2011
3	ConalbuminIBA 01/2017 - 09/2015
3	Nitric Oxide Synthase (NO Synthase)IBA 05/2016 - 10/2009
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2015 - 04/2013
3	LectinsIBA 02/2015 - 05/2012
3	Matrix Metalloproteinase 2 (Gelatinase A)IBA 12/2013 - 01/2004
2	peptide VIBA 02/2024 - 06/2022
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2024 - 09/2010
2	ursodoxicoltaurineIBA 01/2023 - 06/2022
2	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2017
2	Antihypertensive Agents (Antihypertensives)IBA 03/2022 - 10/2016
2	Endothelins (Endothelin)IBA 01/2022 - 01/2003
2	CollagenIBA 01/2020 - 02/2003
2	salicylhydroxamic acid (SHAM)IBA 01/2020 - 09/2017
2	Metalloproteases (Metalloproteinases)IBA 01/2017 - 01/2005
2	Vasoconstrictor AgentsIBA 10/2016 - 11/2005
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2016 - 01/2012
2	Sildenafil Citrate (Viagra)FDA Link 12/2015 - 05/2012
2	tanshinoneIBA 01/2015 - 10/2009
2	Propofol (Diprivan)FDA LinkGeneric 04/2013 - 07/2009
2	AngiotensinsIBA 01/2013 - 01/2012
2	LDL Lipoproteins (beta Lipoproteins)IBA 05/2012 - 02/2009
2	ArginaseIBA 01/2010 - 10/2009
2	Tissue Inhibitor of Metalloproteinase-1IBA 01/2005 - 01/2004
2	Tissue Inhibitor of Metalloproteinase-2IBA 01/2005 - 01/2004
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 02/2024
1	3-nitrotyrosineIBA 02/2024
1	Cyclooxygenase 1IBA 01/2024
1	Toll-Like Receptor 4IBA 01/2024
1	IronIBA 11/2023
1	Scavenger Receptors (Scavenger Receptor)IBA 10/2023
1	NADP (NADPH)IBA 10/2023
1	Phosphotransferases (Kinase)IBA 10/2023
1	Oxidoreductases (Dehydrogenase)IBA 10/2023
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 10/2023
1	Superoxide DismutaseIBA 10/2023
1	acetovanillone (apocynin)IBA 10/2023
1	Succinic Acid (Succinate)IBA 09/2023
1	NAD (NADH)IBA 09/2023
1	AtrasentanIBA 01/2023
1	CytosineIBA 01/2023
1	Endothelin Receptors (Endothelin Receptor)IBA 01/2023
1	Activating Transcription Factor 6IBA 01/2023
1	Phosphates (Orthophosphate)IBA 01/2023
1	GuanosineIBA 01/2023
1	Endoplasmic Reticulum Chaperone BiPIBA 01/2023
1	mesoglycanIBA 10/2022
1	p38 Mitogen-Activated Protein KinasesIBA 06/2022

Therapy/Procedure

4	Therapeutics 04/2016 - 01/2013
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2015 - 10/2009
2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 08/2009 - 07/2004
1	Oral Administration 02/2024